chr4-161386405-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_020116.5(FSTL5):āc.1886T>Cā(p.Ile629Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000769 in 1,613,404 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 32)
Exomes š: 0.000082 ( 4 hom. )
Consequence
FSTL5
NM_020116.5 missense
NM_020116.5 missense
Scores
2
10
7
Clinical Significance
Conservation
PhyloP100: 7.04
Genes affected
FSTL5 (HGNC:21386): (follistatin like 5) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.12221661).
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSTL5 | NM_020116.5 | c.1886T>C | p.Ile629Thr | missense_variant | 16/16 | ENST00000306100.10 | NP_064501.2 | |
FSTL5 | NM_001128427.3 | c.1883T>C | p.Ile628Thr | missense_variant | 16/16 | NP_001121899.1 | ||
FSTL5 | NM_001128428.3 | c.1856T>C | p.Ile619Thr | missense_variant | 15/15 | NP_001121900.1 | ||
FSTL5 | XM_011532126.1 | c.1859T>C | p.Ile620Thr | missense_variant | 15/15 | XP_011530428.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSTL5 | ENST00000306100.10 | c.1886T>C | p.Ile629Thr | missense_variant | 16/16 | 1 | NM_020116.5 | ENSP00000305334 | P5 | |
FSTL5 | ENST00000379164.8 | c.1883T>C | p.Ile628Thr | missense_variant | 16/16 | 1 | ENSP00000368462 | A1 | ||
FSTL5 | ENST00000427802.2 | c.1856T>C | p.Ile619Thr | missense_variant | 15/15 | 1 | ENSP00000389270 | A1 | ||
ENST00000508189.1 | n.828A>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152144Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152144
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000153 AC: 38AN: 249032Hom.: 1 AF XY: 0.000171 AC XY: 23AN XY: 134604
GnomAD3 exomes
AF:
AC:
38
AN:
249032
Hom.:
AF XY:
AC XY:
23
AN XY:
134604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000821 AC: 120AN: 1461142Hom.: 4 Cov.: 33 AF XY: 0.000111 AC XY: 81AN XY: 726848
GnomAD4 exome
AF:
AC:
120
AN:
1461142
Hom.:
Cov.:
33
AF XY:
AC XY:
81
AN XY:
726848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74446
GnomAD4 genome
AF:
AC:
4
AN:
152262
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
18
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.1886T>C (p.I629T) alteration is located in exon 16 (coding exon 15) of the FSTL5 gene. This alteration results from a T to C substitution at nucleotide position 1886, causing the isoleucine (I) at amino acid position 629 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at